Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2018

Jan 8, 2018

29821_dirs_2018-01-08_b370f611-157c-44c0-92d9-03c657845919.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-01-01

Reporting Person: Wang Xin Warren (SVP and Pres, Asia Pacific)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 92531.0000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Deferred Stock Units $ 2020-02-23 Common Stock (6346.0000) Direct
Deferred Stock Units $ 2019-02-24 Common Stock (5276.0000) Direct
Deferred Stock Units $ 2018-02-28 Common Stock (9337.0000) Direct
Deferred Stock Units $ 2022-02-28 Common Stock (8146.0000) Direct
Deferred Stock Units $ 2019-10-27 Common Stock (3052.0000) Direct
Deferred Stock Units $ 2018-10-29 Common Stock (2545.0000) Direct
Deferred Stock Units $ 2020-12-01 Common Stock (6075.0000) Direct
Stock Option (Right to Buy) $13.0800 2024-02-24 Common Stock (34500.0000) Direct
Stock Option (Right to Buy) $16.3100 2025-02-23 Common Stock (32003.0000) Direct
Stock Option (Right to Buy) $18.5200 2025-12-01 Common Stock (30637.0000) Direct
Stock Option (Right to Buy) $24.5500 2027-02-28 Common Stock (28860.0000) Direct

Footnotes

F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F3: This amount represents the unvested portion of DSUs awarded on February 23, 2015, which will continue to vest in three remaining installments on the anniversary of the date of grant.

F4: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

F6: This amount represents the unvested portion of DSUs awarded on February 24, 2014, which will continue to vest in two remaining installments on the anniversary of the date of grant.

F7: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.

F8: This amount represents the unvested portion of DSUs awarded on February 28, 2013, which will continue to vest in one remaining installment on the anniversary of the date of grant.

F9: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

F10: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 27, 2015, the first anniversary of the date of grant.

F11: This amount represents the unvested portion of DSUs awarded on October 27, 2014, which will continue to vest in two remaining installments on the anniversary of the date of grant.

F12: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 29, 2014, the first anniversary of the date of grant.

F13: This amount represents the unvested portion of DSUs awarded on October 29, 2013, which will continue to vest in one remaining installment on the anniversary of the date of grant.

F14: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant.

F15: This amount represents the unvested portion of DSUs awarded on December 1, 2015, which will continue to vest in three remaining installments on the anniversary of the date of grant.

F16: Grant to the reporting person of an option to purchase a 34,500 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

F17: Grant to the reporting person of an option to purchase a 32,003 shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F18: Grant to the reporting person of an option to purchase a 30,637 shares of common stock vesting in four equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant.

F19: Grant to the reporting person of an option to purchase a 28,860 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.